bf/NASDAQ:VRTX_icon.jpeg

NASDAQ:VRTX

Vertex Pharmaceuticals Incorporated

  • Stock

USD

Last Close

416.25

06/11 21:01

Market Cap

126.86B

Beta: 0.49

Volume Today

1.45M

Avg: 1.12M

PE Ratio

31.95

PFCF: 26.33

    Description

    Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients ...Show More

    Earnings

    Earnings per Share (Estimate*)

    12342017-01-252019-02-052021-02-012023-02-072024-08-01

    Revenue (Estimate*)

    1B2B3B4B2017-01-252019-02-052021-02-012023-02-072024-08-01

    *Estimate based on analyst consensus